Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 923 entries
View as:

Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX

Phase: N/A Priority: Normal
NCT ID: NCT03134456 Org: User:
Start: 05/14/18 End: 07/13/23 Due: 07/13/24

Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00922012 Org: User:
Start: 11/30/07 End: 12/31/09 Due: 12/31/10

Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00903045 Org: User:
Start: 01/31/05 End: 08/31/06 Due: 08/31/07

A Trial of JX-594 in Refractory Colorectal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01469611 Org: User:
Start: 07/31/10 End: 01/31/15 Due: 01/31/16

App-based Cognitive Training at Home

Phase: N/A Priority: Normal
NCT ID: NCT03494699 Org: User:
Start: 03/22/18 End: 12/01/19 Due: 12/01/20

Hemostatic Effect of Various Colloid Solutions

Phase: N/A Priority: Normal
NCT ID: NCT00518544 Org: User:
Start: 07/31/07 End: - Due: -

Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT02379663 Org: User:
Start: 01/31/12 End: 01/31/13 Due: 01/31/14

The Effect of EX1 Training in Normal Adults

Phase: N/A Priority: Normal
NCT ID: NCT05266170 Org: User:
Start: 03/23/22 End: 12/28/22 Due: 12/28/23

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05893966 Org: User:
Start: 11/29/22 End: 11/29/32 Due: 11/29/33

Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)

Phase: N/A Priority: Normal
NCT ID: NCT01281761 Org: User:
Start: 11/30/10 End: 12/31/12 Due: 12/31/13

Patritumab Deruxtecan in Patients with Solid Tumor Harboring an NRG1 Fusion

Phase: N/A Priority: Normal
NCT ID: NCT06383884 Org: User:
Start: 08/13/24 End: 04/30/29 Due: 04/30/30

Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01996761 Org: User:
Start: 01/31/11 End: 02/28/14 Due: 02/28/15

Evaluation of SVV From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02277353 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)

Phase: N/A Priority: Normal
NCT ID: NCT05453682 Org: User:
Start: 05/14/21 End: 12/31/29 Due: 12/31/30

Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT03045692 Org: User:
Start: 02/13/17 End: 04/30/19 Due: 04/30/20

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT06041893 Org: User:
Start: 05/29/23 End: 12/31/25 Due: 12/31/26

Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF

Phase: N/A Priority: Normal
NCT ID: NCT03554837 Org: User:
Start: 04/20/18 End: 01/31/21 Due: 01/31/22

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00374699 Org: User:
Start: 04/30/06 End: 10/31/09 Due: 10/31/10

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection

Phase: N/A Priority: Normal
NCT ID: NCT05797545 Org: User:
Start: 04/23/23 End: 05/28/28 Due: 05/28/29

Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02754739 Org: User:
Start: 04/15/14 End: 08/31/17 Due: 08/31/18

A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01913119 Org: User:
Start: 07/31/13 End: 07/31/13 Due: 07/31/14

Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01082809 Org: User:
Start: 03/31/09 End: 02/29/12 Due: 02/28/13

Establishing a Cohort for Occupational Disease of Emergency Medical Workers

Phase: N/A Priority: Normal
NCT ID: NCT05357365 Org: User:
Start: 05/09/22 End: 12/31/23 Due: 12/31/24

Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01312337 Org: User:
Start: 09/30/10 End: - Due: -

Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01622751 Org: User:
Start: 01/31/07 End: 06/30/07 Due: 06/30/08